CVS Health is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies in the coming months. Details of the strategic shift were announced in a CVS corporate memo dated Oct. 8 and seen by Reuters. The company on Oct. 8 stopped taking new patients seeking antibiotics, drugs supporting muscular health, and intravenous nutrition services. CVS bought Coram LLC, a drug infusion services provider, for $2.1 billion in 2013.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
